Cargando…
The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast
It is widely believed that infection with the SARS-CoV-2 virus triggers a disproportionate immune response which causes a devastating systemic injury, particularly in individuals with obesity, itself a chronic, multi-organ inflammatory disease. Immune cells accumulate in visceral adipose tissue and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255216/ https://www.ncbi.nlm.nih.gov/pubmed/32492562 http://dx.doi.org/10.1016/j.mehy.2020.109883 |